These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 405043)

  • 1. Enzymological properties and immunological characterization of alpha-galactosidase isoenzymes from normal and Fabry human liver.
    Schram AW; Hamers MN; Brouwer-Kelder B; Donker-Koopman WE; Tager JM
    Biochim Biophys Acta; 1977 May; 482(1):125-37. PubMed ID: 405043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
    Rietra PJ; Van den Bergh FA; Tager JM
    Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identity of alpha-galactosidase B from human liver.
    Schram AW; Hamers MN; Tager JM
    Biochim Biophys Acta; 1977 May; 482(1):138-44. PubMed ID: 405044
    [No Abstract]   [Full Text] [Related]  

  • 4. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
    Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of alpha-galactosidase isoenzymes in normal and Fabry human-Chinese Hamster somatic cell hybrids.
    Hamers MN; Westerveld A; Khan M; Tager JM
    Hum Genet; 1977 May; 36(3):289-97. PubMed ID: 404232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of two forms of N-acetyl-alpha-galactosaminidase from human liver.
    Schram AW; De Groot PG; Hamers MN; Brouwer-Kelder B; Donker-Koopman WE; Tager JM
    Biochim Biophys Acta; 1978 Aug; 525(2):410-6. PubMed ID: 210819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two immunologically distinct human acidic beta-galactosidase A isozymes.
    Ben-Yoseph Y; Shapira E; Nadler HL
    Enzyme; 1977; 22(4):276-82. PubMed ID: 560298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human alpha-galactosidase A and B before and after neuraminidase treatment.
    Romeo G; Di Matteo G; D'urso M; Li SC; Li YT
    Biochim Biophys Acta; 1975 Jun; 391(2):349-60. PubMed ID: 167833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease.
    Kase R; Bierfreund U; Klein A; Kolter T; Utsumi K; Itoha K; Sandhoff K; Sakuraba H
    Biochim Biophys Acta; 2000 Jun; 1501(2-3):227-35. PubMed ID: 10838196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E; Schono N; Kozlova I; Wiederschain G
    Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Galactosidase isozymes in normal individuals, and in Fabry hemizygotes and heterozygotes.
    Sørensen SA; Hasholt L
    Ann Hum Genet; 1980 May; 43(4):313-21. PubMed ID: 6772088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.
    Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC
    Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.
    Lemansky P; Bishop DF; Desnick RJ; Hasilik A; von Figura K
    J Biol Chem; 1987 Feb; 262(5):2062-5. PubMed ID: 3029062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
    Rietra PJ; Molenaar JL; Hamers MN; Tager JM; Borst P
    Eur J Biochem; 1974 Jul; 46(1):89-98. PubMed ID: 4212108
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of multiple molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from normal and Fabry leukocytes.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Eur J Biochem; 1979 Oct; 100(2):377-83. PubMed ID: 41709
    [No Abstract]   [Full Text] [Related]  

  • 17. I-Cell disease: isoelectric focusing, concanavalin A-Sepharose 4B binding and kinetic properties of human liver acid beta-D-galactosidases.
    Miller AL
    Biochim Biophys Acta; 1978 Jan; 522(1):174-86. PubMed ID: 413580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma alpha-galactosidase A:properties and comparisons with tissue alpha-galactosidases.
    Bishop DF; Sweeley CC
    Biochim Biophys Acta; 1978 Aug; 525(2):399-409. PubMed ID: 210818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
    Kano I; Yamakawa T
    Chem Phys Lipids; 1974 Dec; 13(4):283-91. PubMed ID: 4217662
    [No Abstract]   [Full Text] [Related]  

  • 20. Fabry disease: diagnosis by alpha-galactosidase activities in tears.
    Johnson DL; Del Monte MA; Cotlier E; Desnick RJ
    Clin Chim Acta; 1975 Aug; 63(1):81-90. PubMed ID: 241513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.